Anti-Human FGF21 Reference Antibody (ARX618)

Anti-Human FGF21 Reference Antibody (ARX618)

  • Catalog number: BS11328
  • Availability: In Stock
  • $370.00

  • Ex Tax: $370.00


Available Options

Qty
Description: Anti-Human FGF21 (ARX618) (BS11328) is a research-grade recombinant antibody targeting FGF21. Produced in mammalian cells with native-like glycosylation.
Highlights:
• Research Grade — For PK/PD studies, assay development, and ADA research.
• Native Glycosylation — Mammalian expression ensures native-like patterns.
Host species: Human
Isotype: IgG
Species reactivity: Human
Immunogen:
Form: Liquid
Storage instructions:
Storage buffer: 0.01M PBS, pH7.4.
Concentration: 1mg/ml
Purity: >95% as determined by SDS-PAGE.
Clonality: Monoclonal
Applications: Research Grade Biosimilar
Target: FGF21,Fibroblastgrowthfactor21,FGF-21
Purification: Protein A/G purified from cell culture supernatant.
Endotoxin level: <1EU/mg, determined by LAL gel clotting assay
Expression system: Mammalian Cells
Stability and Storage: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.
Alternative Names: ARX618
Background: Fibroblast growth factor 21 (FGF21) is a ~22 kDa protein. Stimulates glucose uptake in differentiated adipocytes via the induction of glucose transporter SLC2A1/GLUT1 expression (but not SLC2A4/GLUT4 expression). Activity requires the presence of KLB. Regulates systemic glucose homeostasis and insulin sensitivity.
Note: For research use only. Not suitable for clinical or therapeutic use.

Images

  • Bioactivity for Anti-Human FGF21 Reference Antibody (ARX618)
    Bioactivity

    Detects HRSV-A2 Pre-F/Fusion glycoprotein F0 (PV10554) in indirect ELISAs.

Be the first to write a review for this product.

Write a review

Note: HTML is not translated!
Bad           Good